Fabian Alt, M.Sc.
Chief Financial Officer
Fabian Alt previously served in the Investment Banking Division of Goldman Sachs’s London office. His experience extends across more than 20 completed capital market and M&A transactions, including several equity capital offerings and IPOs. Fabian received his master’s in finance from the London School of Economics and Political Science, earned an honors master’s in technology management from the Technical University of Munich and Ludwig-Maximilians-University Munich, and received a master’s in physics from the Technical University of Munich. In addition, he completed research stays at the Max Planck Institute for Quantum Optics and Massachusetts Institute of Technology.
Robert T. Charles
Director of Quality
Robert Charles has over 30 years of experience in quality and reliability assurance management in the medical industry. He has held leadership position at several large healthcare companies including Cyberonics, Intermedics, Abbott Laboratories, and St. Jude Medical. He has a proven track record of quality planning, operation, and management.
Annette M. Zinn, J.D., Ph.D.
Director of Regulatory Affairs
Annette M. Zinn, J.D., Ph.D., is a regulatory attorney with over 25 years of regulatory experience in the medical device industry. Previously she was regulatory counsel at Cyberonics for 13 years and regulatory specialist at Intermedics, Inc. for 7 years. During her career she has overseen successful pre-market approval applications (PMA) to the U.S. Food and Drug Administration. She instructed LLM students in FDA law and regulations at the University of Houston, Bates College of Law. She has a law degree from South Texas College of Law and is licensed to practice in the State of Texas. She has both M.P.H. and Ph.D. degrees from the University of Texas Houston, School of Public Health, where her research included the effect of modernization laws on FDA/CMS approvals.
Director of Engineering and Product Operations
David Mercer has more than 12 years of product development experience in medical devices. Previously, he worked at Acelity as Lead Product Development Engineer developing new negative pressure therapy devices within the Prevena and Abthera surgical product lines. Before Acelity David developed mechanical and electromechanical drug delivery systems at DCA Design International in the UK. David received his degree in mechanical engineering specializing in product design from The University of Glasgow.
Christopher Alt, MD
Director of Medical and Scientific Affairs
Christopher Alt has 15 years of research experience in medicine and has a proven track record of clinical trial management. Previously, he worked at MD Anderson Cancer Center in the department of molecular pathology. Christopher joined InGeneron in 2015 as European director of medical and scientific affairs before taking on the role of global director of medical and scientific affairs in 2020. Christopher received his medical degree from PMU Salzburg in Austria.